BNP Paribas Financial Markets’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-252
| Closed | -$69 | – | 4229 |
|
|
2022
Q3 | $69 | Hold |
252
| – | – | ﹤0.01% | 3947 |
|
|
2022
Q2 | $88 | Hold |
252
| – | – | ﹤0.01% | 3382 |
|
|
2022
Q1 | $171 | Sell |
252
-185
| -42% | -$126 | ﹤0.01% | 3508 |
|
|
2021
Q4 | $1.01K | Sell |
437
-50
| -10% | -$115 | ﹤0.01% | 3403 |
|
|
2021
Q3 | $2.23K | Hold |
487
| – | – | ﹤0.01% | 3182 |
|
|
2021
Q2 | $2.16K | Sell |
487
-1,616
| -77% | -$7.17K | ﹤0.01% | 3273 |
|
|
2021
Q1 | $15.3K | Sell |
2,103
-979
| -32% | -$7.13K | ﹤0.01% | 3225 |
|
|
2020
Q4 | $23.5K | Sell |
3,082
-157
| -5% | -$1.2K | ﹤0.01% | 3156 |
|
|
2020
Q3 | $29.4K | Buy |
3,239
+1,911
| +144% | +$17.4K | ﹤0.01% | 3069 |
|
|
2020
Q2 | $11.2K | Sell |
1,328
-1,469
| -53% | -$12.4K | ﹤0.01% | 3027 |
|
|
2020
Q1 | $13.8K | Buy |
2,797
+1,614
| +136% | +$7.97K | ﹤0.01% | 3367 |
|
|
2019
Q4 | $8.52K | Sell |
1,183
-151
| -11% | -$1.09K | ﹤0.01% | 3476 |
|
|
2019
Q3 | $14.4K | Buy |
1,334
+371
| +39% | +$4.01K | ﹤0.01% | 3434 |
|
|
2019
Q2 | $12.5K | Buy |
+963
| New | +$12.5K | ﹤0.01% | 3428 |
|